Skip to main content
OpenTrials
Completed

NCT Number: NCT02883933

Clinical and Histological Features of Head and Neck Melanoma

The worldwide incidence of cutaneous melanoma has been increasing for the last 30 years in western populations. Among all melanomas, those located on the head and neck are more frequent than expected regarding the surface of this anatomical area, occur in older subjects than melanomas at other sites and have a worse prognosis than melanomas at other sites. The question whether head and neck melanomas could be a distinct entity has been debated.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Aim of the study was to compare clinical and histological characteristics between head and neck melanomas and melanomas at other sites.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with melanoma
  • melanoma diagnosed between January 2004 and December 2011
  • patients living in Champagne-Ardenne

Treatment and study plan

Data Collection

Other

Primary outcomes

  1. Location of melanoma

    Time frame: Day 0

    Location of melanoma was classified in head and neck (scalp, forehead, temples, ears, neck, eyelids, nose, cheeks and area around mouse/chin) or other location (upper limb, lower limb, trunk, hand and foot).

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Acronym: head neck-mel

Important dates

Study start
2004
Primary completion
2011
Study completion
2013
First posted
Aug 30, 2016
Registry last updated
Aug 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.